trans-2-(4-Bromo-phenyl)-cyclohexanol

racemic 2-(4-bromo-phenyl)-trans-cyclopropanecarboxylic acid N-methoxy-N-methyl-amide

4-[[2-(4-Bromo-phenyl)-2-oxo-ethyl]-(2,2,2-trichloro-acetyl)-amino]-benzoic acid ethyl ester

3-[2-(4-Bromo-phenyl)-2-oxo-ethyl]-5,7-dimethyl-[1,2,4]triazolo[1,5-a]pyrimidin-3-ium; bromide

1-[2-(4-Bromo-phenyl)-4-phenyl-[1,3]dioxolan-2-ylmethyl]-1H-imidazole; compound with nitric acid

1-[2-(4-Bromo-phenyl)-4-p-tolyl-[1,3]dioxolan-2-ylmethyl]-1H-imidazole; compound with nitric acid

(Z)-2-(4-Bromo-phenyl)-3-phenyl-acrylonitrile

4-((Cyclohexylamino)methyl)benzoic acid hydrochloride

1-[(2,4-Dichlorophenyl)methyl]-N-(1,1-dimethylethyl)-2-methyl-1H-indole-3-methanamine

2-Methoxy-6-(pyrazol-1-yl)-benzonitrile

1H-3-Benzazepin-7-ol, 8-chloro-2,3,4,5-tetrahydro-5-(3-iodophenyl)-3-methyl-, (S)-

(4-Methyl-tetrahydro-furan-2-yl)-methanol

N-(1-cyanocyclopentyl)-2-[4-(4-fluorobenzenesulfonyl)-1,4-diazepan-1-yl]acetamide

(2-(Aminomethyl)morpholino)(6-methylpyridin-2-yl)methanone

4-(6-Chloropyridazine-3-carbonyl)-1,4-oxazepane

4,5,6,7-Tetrahydrobenzo[d]isoxazole-3-carbaldehyde

tert-Butyl-DL-alanine